Explore 2 life science startups that raised post-ipo secondary funding. Access verified founder contact information and fundraising data.
Get founder emails, funding data, and company details in one CSV
Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.
Werewolf Therapeutics operates as an oncology biotherapeutics company.
Get verified founder emails, funding details, and company data for 2 post-ipo secondary life science companies.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked